Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease.
Djalila MekahliMax Christoph LiebauMelissa A CadnapaphornchaiStuart L GoldsteinLarry A GreenbaumMieczyslaw LitwinTomas SeemanFranz SchaeferLisa M Guay-WoodfordPublished in: BMC nephrology (2023)
Study 204: EudraCT 2020-005991-36; Study 307: EudraCT 2020-005992-10.